CYFRA 21-1 levels (ng·ml -1 ) in benign lung disease | Download Table
PDF) CYFRA 21-1 as a biological marker of lung cancer. Evaluation of sensitivity, specificity and prognostic role
Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J Can Res Ther
Cancers | Free Full-Text | Current and Prospective Protein Biomarkers of Lung Cancer | HTML
PDF) CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA | jaume pahisa - Academia.edu
Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J Can Res Ther
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma
PDF) Urinary CYFRA 21.1 Is Not a Useful Marker for the Detection of Recurrences in the Follow-Up of Superficial Bladder Cancer | Roberto González - Academia.edu
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer - ScienceDirect
PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
Table 6 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar
Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J Can Res Ther
Cancers | Free Full-Text | Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
PDF) Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1
![PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bdba421605be5e232b261c12588773538791f229/3-Table4-1.png "PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar")
PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar
Tumor Markers in Lung Cancer - American Association for Clinical ...
Urinary CYFRA 21.1 Is Not a Useful Marker for the Detection of Recurrences in the Follow-Up of Superficial Bladder Cancer - European Urology
Lung tumor markers of cytokeratin origin: an overview - Lung Cancer
Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA) | Semantic Scholar
Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung Cancer - CHEST
Clinical Equivalence of Two Cytokeratin Markers in Non-small Cell Lung Cancer* - CHEST
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer
Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... | Download Scientific Diagram
Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer | Scientific Reports
![PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/83dc660dc7808a39e51189599c6720de87c99b00/6-Table3-1.png "PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar")
PDF] Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. | Semantic Scholar
CYFRA 21-1 levels (ng·ml -1 ) in benign lung disease | Download Table
